# A Research Study to See How Insulin Icodec Helps People With Type 1 Diabetes Control Their Blood Sugar

> **NCT07160816** · — · RECRUITING · sponsor: **Novo Nordisk A/S** · enrollment: 245 (estimated)

## Conditions studied

- Diabetes Mellitus, Type 1

## Interventions

- **DRUG:** Insulin icodec

## Key facts

- **NCT ID:** NCT07160816
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-08-28
- **Primary completion:** 2027-01-20
- **Final completion:** 2027-01-20
- **Target enrollment:** 245 (ESTIMATED)
- **Last updated:** 2026-04-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07160816

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07160816, "A Research Study to See How Insulin Icodec Helps People With Type 1 Diabetes Control Their Blood Sugar". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07160816. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*